Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The study is a multicenter phase II randomized controlled trial. The purpose is to investigate the efficacy and safety of adjuvant immunotherapy combined with chemoradiation for patients with high-risk resectable extrahepatic cholangiocarcinoma and gallbladder cancer.
Epistemonikos ID: c33492e518a21750348ef40c5ba7be90a2cc700f
First added on: May 07, 2024